Emergency reversal of anticoagulation: from theory to real use of prothrombin complex concentrates. A retrospective Italian experience. （開啟新視窗）

Barillari G, Pasca S, Barillari A, De Angelis V.

來源‎: Blood Transfus 2012;10(1):87-94.

檢索‎: PubMed 22044952

DOI碼‎: 10.2450/2011.0030-11

https://www.ncbi.nlm.nih.gov/pubmed/22044952 （開啟新視窗）

Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. （開啟新視窗）

Douketis JD, Spyropoulos AC, Spencer FA, Mayr M, Jaffer AK, Eckman MH, Dunn AS, Kunz R; American College of Chest Physicians.

來源‎: Chest 2012;141(2 Suppl):e326S-50S.

檢索‎: PubMed 22315266

DOI碼‎: 10.1378/chest.11-2298

https://www.ncbi.nlm.nih.gov/pubmed/22315266 （開啟新視窗）

Pharmacological prophylaxis of bleeding in surgical patients treated with aspirin. （開啟新視窗）

Flordal PA.

來源‎: Eur J Anaesthesiol Suppl 1997;14:38-41.

檢索‎: PubMed 9088834

https://www.ncbi.nlm.nih.gov/pubmed/9088834 （開啟新視窗）

Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. （開啟新視窗）

Goldstein JN, Refaai MA, Milling TJ Jr, Lewis B, Goldberg-Alberts R, Hug BA, Sarode R.

來源‎: Lancet 2015;385(9982):2077-87.

檢索‎: PubMed 25728933

DOI碼‎: 10.1016/S0140-6736(14)61685-8

https://www.ncbi.nlm.nih.gov/pubmed/25728933 （開啟新視窗）

How I treat warfarin-associated coagulopathy in patients with intracerebral hemorrhage. （開啟新視窗）

Goodnough LT, Shander A.

來源‎: Blood 2011;117(23):6091-9.

檢索‎: PubMed 21411756

DOI碼‎: 10.1182/blood-2010-11-316075

https://www.ncbi.nlm.nih.gov/pubmed/21411756 （開啟新視窗）

Long-term safety and efficacy of a pasteurized nanofiltrated prothrombin complex concentrate (Beriplex P/N): a pharmacovigilance study. （開啟新視窗）

Hanke AA, Joch C, Görlinger K.

來源‎: Br J Anaesth 2013;110(5):764-72.

檢索‎: PubMed 23335567

DOI碼‎: 10.1093/bja/aes501

https://www.ncbi.nlm.nih.gov/pubmed/23335567 （開啟新視窗）

Reversing the effects of antiplatelet agents in the setting of intracranial hemorrhage: a look at the literature. （開啟新視窗）

Jaben EA, Mulay SB, Stubbs JR.

來源‎: J Intensive Care Med 2015;30(1):3-7.

檢索‎: PubMed 25492811

DOI碼‎: 10.1177/0885066613487298

https://www.ncbi.nlm.nih.gov/pubmed/25492811 （開啟新視窗）

Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents. （開啟新視窗）

Levi M, Eerenberg E, Kamphuisen PW.

來源‎: J Thromb Haemost 2011;9(9):1705-12.

檢索‎: PubMed 21729240

DOI碼‎: 10.1111/j.1538-7836.2011.04432.x

https://www.ncbi.nlm.nih.gov/pubmed/21729240 （開啟新視窗）

Emergency reversal of warfarin anticoagulation. （開啟新視窗）

Lin Y, Callum J.

來源‎: CMAJ 2010;182(18):2004.

檢索‎: PubMed 21078740

DOI碼‎: 10.1503/cmaj.100983

https://www.ncbi.nlm.nih.gov/pubmed/21078740 （開啟新視窗）

Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: a randomised crossover ex vivo study in healthy volunteers. （開啟新視窗）

Marlu R, Hodaj E, Paris A, Albaladejo P, Cracowski JL, Pernod G.

來源‎: Thromb Haemost 2012;108(2):217-24.

檢索‎: PubMed 22627883

DOI碼‎: 10.1160/TH12-03-0179

https://www.ncbi.nlm.nih.gov/pubmed/22627883 （開啟新視窗）

Recent advances in the development of specific antidotes for target-specific oral anticoagulants. （開啟新視窗）

Mo Y, Yam FK.

來源‎: Pharmacotherapy 2015;35(2):198-207.

檢索‎: PubMed 25644580

DOI碼‎: 10.1002/phar.1532

https://www.ncbi.nlm.nih.gov/pubmed/25644580 （開啟新視窗）

Idarucizumab for dabigatran reversal - full cohort analysis. （開啟新視窗）

Pollack CV Jr, Reilly PA, van Ryn J, Eikelboom JW, Glund S, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kam CW, Kamphuisen PW, Kreuzer J, Levy JH, Royle G, Sellke FW, Stangier J, Steiner T, Verhamme P, Wang B, Young L, Weitz JI

來源‎: N Engl J Med 2017;377(5):431-41.

檢索‎: PubMed 28693366

DOI碼‎: 10.1056/NEJMoa1707278

https://www.ncbi.nlm.nih.gov/pubmed/28693366 （開啟新視窗）

Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory study. （開啟新視窗）

Skolnick BE, Shenouda M, Khutoryansky NM, Pusateri AE, Gabriel D, Carr ME.

來源‎: Anesth Analg 2011;113(4):703-10.

檢索‎: PubMed 21890888

DOI碼‎: 10.1213/ANE.0b013e318228c690

https://www.ncbi.nlm.nih.gov/pubmed/21890888 （開啟新視窗）

Oral anticoagulation in surgical procedures: risks and recommendations. （開啟新視窗）

Torn M, Rosendaal FR.

來源‎: Br J Haematol 2003;123(4):676-82.

檢索‎: PubMed 14616972

https://www.ncbi.nlm.nih.gov/pubmed/14616972 （開啟新視窗）

Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding. （開啟新視窗）

Warkentin TE, Margetts P, Connolly SJ, Lamy A, Ricci C, Eikelboom JW.

來源‎: Blood 2012;119(9):2172-4.

檢索‎: PubMed 22383791

DOI碼‎: 10.1182/blood-2011-11-393587

https://www.ncbi.nlm.nih.gov/pubmed/22383791 （開啟新視窗）